Indications for red cell transfusion in sickle cell disease

Area of Science:

• Hematology
• Transfusion Medicine
• Pediatric Hematology

Background:

• Red blood cell transfusion (RCT) is a cornerstone therapy for sickle cell disease (SCD).
• Indications for RCT in SCD range from clear necessity to controversial or ill-advised situations.
• RCT can be administered episodically or chronically to manage SCD.

Purpose of the Study:

• To review the established and emerging indications for red blood cell transfusion in sickle cell disease management.
• To differentiate between episodic and chronic transfusion strategies.
• To highlight the role of chronic transfusion in preventing primary and recurrent cerebrovascular events.

Main Methods:

• Literature review of clinical guidelines and research studies on red blood cell transfusion in SCD.
• Analysis of evidence supporting episodic and chronic transfusion protocols.
• Examination of transfusion use in preventing SCD complications, particularly stroke.

Main Results:

• RCT is clearly indicated in specific SCD clinical scenarios.
• Episodic transfusions address acute complications or reduce their likelihood.
• Chronic transfusion therapy is effective in preventing stroke recurrence and, recently, primary stroke occurrence.

Conclusions:

• Red blood cell transfusion is a critical therapeutic tool in sickle cell disease care.
• The judicious application of episodic and chronic transfusion strategies is essential for optimal patient outcomes.
• Chronic transfusion therapy shows promise in primary stroke prevention for at-risk SCD patients.